HCA HEALTHCARE INC (HCA) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:HCA - US40412C1018 - Common Stock
472.07 USD
-6.95 (-1.45%)
472.07 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 60.233B 2.52% | 64.968B 7.86% | 70.603B 8.67% | 76.498B 8.35% | 79.919B 4.47% | 84.035B 5.15% | 90.05B 7.16% | 94.823B 5.30% | 98.593B 3.98% | 103.056B 4.53% | 107.725B 4.53% | 112.608B 4.53% | |
| EBITDA YoY % growth | 12.022B -4.06% | 12.704B 5.67% | 13.859B 9.09% | 15.57B 12.35% | 16.038B 3.01% | 16.87B 5.19% | 17.628B 4.49% | 18.657B 5.84% | 19.566B 4.87% | 20.709B 5.84% | 21.648B 4.53% | 22.625B 4.51% | |
| EBIT YoY % growth | 9.053B -6.46% | 9.627B 6.34% | 10.547B 9.56% | 12.077B 14.51% | 12.386B 2.56% | 13.002B 4.97% | 13.387B 2.96% | 14.256B 6.49% | 14.937B 4.78% | 15.871B 6.25% | 16.589B 4.52% | 17.342B 4.54% | |
| Operating Margin | 15.03% | 14.82% | 14.94% | 15.79% | 15.50% | 15.47% | 14.87% | 15.03% | 15.15% | 15.40% | 15.40% | 15.40% | |
| EPS YoY % growth | 16.90 -3.43% | 18.66 10.41% | 22.12 18.54% | 27.88 26.06% | 29.98 7.53% | 33.23 10.83% | 36.88 10.98% | 41.86 13.50% | 47.53 13.55% | 53.91 13.43% | 60.53 12.27% | 67.86 12.11% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 7.51 33.38% | 7.20 11.65% | 7.54 10.34% | 7.31 4.96% | 8.24 9.71% | 7.94 10.23% | 8.35 10.87% | 8.12 11.21% | 8.96 8.80% |
| Revenue Q2Q % growth | 19.863B 8.63% | 19.38B 5.78% | 19.633B 5.53% | 20.082B 4.81% | 20.701B 4.22% | 20.34B 4.95% | 20.606B 4.96% | 21.129B 5.21% | 21.883B 5.71% |
| EBITDA Q2Q % growth | 4.063B -34.02% | 3.911B 5.28% | 4.027B -14.14% | 3.894B -30.18% | 4.227B 4.04% | 4.099B 4.81% | 4.228B 4.99% | 4.174B 7.19% | 4.402B 4.14% |
| EBIT Q2Q % growth | 3.17B 11.38% | 3.028B 6.06% | 3.128B 5.43% | 3.055B 3.04% | 3.329B 5.02% | 3.209B 5.98% | 3.294B 5.31% | 3.267B 6.94% | 3.457B 3.84% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 6.96 38.37% | 5.77 | 1.19 | 20.55% |
| Q2 2025 Q2Q % growth | 6.83 23.51% | 6.31 | 0.52 | 8.18% |
| Q1 2025 Q2Q % growth | 6.45 8.77% | 5.84 | 0.61 | 10.52% |
| Q4 2024 Q2Q % growth | 5.63 -5.06% | 6.18 | -0.55 | -8.93% |
| Q3 2024 Q2Q % growth | 5.03 28.64% | 5.04 | -0.01 | -0.18% |
| Q2 2024 Q2Q % growth | 5.53 28.90% | 4.90 | 0.63 | 12.83% |
| Q1 2024 Q2Q % growth | 5.93 30.91% | 5.04 | 0.89 | 17.74% |
| Q4 2023 Q2Q % growth | 5.93 27.80% | 5.11 | 0.82 | 15.99% |
| Q3 2023 Q2Q % growth | 3.91 -0.51% | 4.02 | -0.11 | -2.67% |
| Q2 2023 Q2Q % growth | 4.29 1.90% | 4.27 | 0.02 | 0.57% |
| Q1 2023 Q2Q % growth | 4.53 9.95% | 3.97 | 0.56 | 14.11% |
| Q4 2022 Q2Q % growth | 4.64 4.98% | 4.83 | -0.19 | -3.95% |
| Q3 2022 Q2Q % growth | 3.93 -14.00% | 3.92 | 0.01 | 0.26% |
| Q2 2022 Q2Q % growth | 4.21 -3.66% | 3.74 | 0.47 | 12.68% |
| Q1 2022 Q2Q % growth | 4.12 -0.48% | 4.29 | -0.17 | -3.99% |
| Q4 2021 Q2Q % growth | 4.42 7.02% | 4.58 | -0.16 | -3.45% |
| Q3 2021 Q2Q % growth | 4.57 138.02% | 4.13 | 0.44 | 10.66% |
| Q2 2021 Q2Q % growth | 4.37 191.33% | 3.19 | 1.18 | 36.81% |
| Q1 2021 Q2Q % growth | 4.14 77.68% | 3.36 | 0.78 | 23.30% |
| Q4 2020 Q2Q % growth | 4.13 | 3.64 | 0.49 | 13.43% |
| Q3 2020 Q2Q % growth | 1.92 | 2.34 | -0.42 | -18.01% |
| Q2 2020 Q2Q % growth | 1.50 | -0.39 | 1.89 | 479.94% |
| Q1 2020 Q2Q % growth | 2.33 | 2.66 | -0.33 | -12.55% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 19.161B 9.57% | 18.748B | 413M | 2.20% |
| Q2 2025 Q2Q % growth | 18.605B 6.36% | 18.68B | -75M | -0.40% |
| Q1 2025 Q2Q % growth | 18.321B 5.66% | 18.43B | -109M | -0.59% |
| Q4 2024 Q2Q % growth | 18.285B 5.68% | 18.413B | -128M | -0.70% |
| Q3 2024 Q2Q % growth | 17.487B 7.86% | 17.713B | -226M | -1.28% |
| Q2 2024 Q2Q % growth | 17.492B 10.28% | 17.217B | 275M | 1.60% |
| Q1 2024 Q2Q % growth | 17.339B 11.21% | 16.947B | 392M | 2.31% |
| Q4 2023 Q2Q % growth | 17.303B 11.65% | 16.682B | 621M | 3.72% |
| Q3 2023 Q2Q % growth | 16.213B 8.30% | 15.981B | 232M | 1.45% |
| Q2 2023 Q2Q % growth | 15.861B 7.02% | 15.772B | 89M | 0.56% |
| Q1 2023 Q2Q % growth | 15.591B 4.32% | 15.419B | 172M | 1.12% |
| Q4 2022 Q2Q % growth | 15.497B 2.87% | 15.767B | -270M | -1.71% |
| Q3 2022 Q2Q % growth | 14.971B -2.00% | 15.151B | -180M | -1.19% |
| Q2 2022 Q2Q % growth | 14.82B 2.67% | 14.872B | -52M | -0.35% |
| Q1 2022 Q2Q % growth | 14.945B 6.93% | 14.886B | 59M | 0.40% |
| Q4 2021 Q2Q % growth | 15.064B 5.39% | 15.526B | -462M | -2.98% |
| Q3 2021 Q2Q % growth | 15.276B 14.76% | 14.628B | 648M | 4.43% |
| Q2 2021 Q2Q % growth | 14.435B 30.42% | 13.756B | 679M | 4.94% |
| Q1 2021 Q2Q % growth | 13.977B 8.68% | 13.772B | 205M | 1.49% |
| Q4 2020 Q2Q % growth | 14.293B | 14.131B | 162M | 1.15% |
| Q3 2020 Q2Q % growth | 13.311B | 12.996B | 315M | 2.42% |
| Q2 2020 Q2Q % growth | 11.068B | 10.192B | 876M | 8.59% |
| Q1 2020 Q2Q % growth | 12.861B | 13.245B | -384M | -2.90% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.04% | 1.59% | 0.14% | 4.78% |
| Revenue | -0.08% | 0.69% | -0.02% | 0.95% |